18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Asthma Is a Risk Factor for Respiratory Exacerbations Without Increased Rate of Lung Function Decline : Five-Year Follow-up in Adult Smokers From the COPDGene Study

      research-article
      , MD, MMSc a , b , , , MD, MPH d , , PhD b , , MD e , , PhD f , , MD, PhD h , , MD g , , MD, PhD b , c , , MD, MPH b , c , COPDGene Investigators
      Role: principle investigator
      Role: principle investigator
      Chest
      American College of Chest Physicians
      asthma-COPD overlap, childhood asthma, childhood pneumonia, COPD, respiratory exacerbations, ACO, asthma-COPD overlap, β, absolute difference, GOLD, Global Initiative for Chronic Obstructive Lung Disease, HU, Hounsfield units, PRM, parametric response mapping, SGRQ, St. George's Respiratory Questionnaire, SRWA-Pi10, square root of the wall area of a hypothetical airway with 10-mm internal perimeter

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Previous investigations in adult smokers from the COPDGene Study have shown that early-life respiratory disease is associated with reduced lung function, COPD, and airway thickening. Using 5-year follow-up data, we assessed disease progression in subjects who had experienced early-life respiratory disease. We hypothesized that there are alternative pathways to reaching reduced FEV 1 and that subjects who had childhood pneumonia, childhood asthma, or asthma-COPD overlap (ACO) would have less lung function decline than subjects without these conditions.

          Methods

          Subjects returning for 5-year follow-up were assessed. Childhood pneumonia was defined by self-reported pneumonia at < 16 years. Childhood asthma was defined as self-reported asthma diagnosed by a health professional at < 16 years. ACO was defined as subjects with COPD who self-reported asthma diagnosed by a health-professional at ≤ 40 years. Smokers with and those without these early-life respiratory diseases were compared on measures of disease progression.

          Results

          Follow-up data from 4,915 subjects were examined, including 407 subjects who had childhood pneumonia, 323 subjects who had childhood asthma, and 242 subjects with ACO. History of childhood asthma or ACO was associated with an increased exacerbation frequency (childhood asthma, P < .001; ACO, P = .006) and odds of severe exacerbations (childhood asthma, OR, 1.41; ACO, OR, 1.42). History of childhood pneumonia was associated with increased exacerbations in subjects with COPD (absolute difference [β], 0.17; P = .04). None of these early-life respiratory diseases were associated with an increased rate of lung function decline or progression on CT scans.

          Conclusions

          Subjects who had early-life asthma are at increased risk of developing COPD and of having more active disease with more frequent and severe respiratory exacerbations without an increased rate of lung function decline over a 5-year period.

          Trial Registry

          ClinicalTrials.gov; No. NCT00608764; https://clinicaltrials.gov.

          Related collections

          Author and article information

          Contributors
          Journal
          Chest
          Chest
          Chest
          American College of Chest Physicians
          0012-3692
          1931-3543
          February 2018
          15 December 2017
          : 153
          : 2
          : 368-377
          Affiliations
          [a ]Division of Respiratory Diseases, Boston Children's Hospital, Boston, MA
          [b ]Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA
          [c ]Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA
          [d ]Clinical Discovery Unit, Early Clinical Discovery, AstraZeneca, Waltham, MA
          [e ]Department of Radiology, National Jewish Health, Denver, CO
          [f ]Division of Biostatistics and Bioinformatics, National Jewish Health, Denver, CO
          [g ]Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO
          [h ]Department of Radiology, University of Edinburgh, Edinburgh, Scotland
          Author notes
          [] CORRESPONDENCE TO: Lystra P. Hayden, MD, MMSc, Channing Division of Network Medicine, Brigham and Women’s Hospital, 181 Longwood Ave, Boston, MA 02115Channing Division of Network MedicineBrigham and Women’s Hospital181 Longwood AveBostonMA02115 lystra.hayden@ 123456childrens.harvard.edu
          Article
          PMC5815872 PMC5815872 5815872 S0012-3692(17)33221-X
          10.1016/j.chest.2017.11.038
          5815872
          29248621
          84a631a9-47d7-4361-802c-e55d9ea14c48
          Copyright © 2017 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
          History
          Categories
          COPD

          SRWA-Pi10, square root of the wall area of a hypothetical airway with 10-mm internal perimeter,SGRQ, St. George's Respiratory Questionnaire,PRM, parametric response mapping,HU, Hounsfield units,GOLD, Global Initiative for Chronic Obstructive Lung Disease,β, absolute difference,ACO, asthma-COPD overlap,respiratory exacerbations,COPD,childhood pneumonia,childhood asthma,asthma-COPD overlap

          Comments

          Comment on this article